Company news
Sichuan Biokin Pharmaceutical Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Voluntary Disclosure of Completing Enrollment of the First Subject in Phase III Clinical Trial of BL-M07D1 (HER2 ADC) for Injection for Postoperative Adjuvant Therapy of HER2-Positive Breast Cancer with Residual Invasive Carcinoma after Neoadjuvant Therapy
June 23, 2025
Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for Share Issuance to Specific Objects (Revised Draft)
June 13, 2025
Announcement on the Revision of the Plan for Issuing A-shares to Specific Objects and Related Documents
May 30, 2025